Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease SANTA ...
EMPOWER CAD, a global prospective, multi-center, real-world study, reaffirms favorable acute outcomes for coronary IVL in female patients, unlike other calcium modification tools PARIS, May 20, 2025 ...
Johnson & Johnson is moving to expand its position in cardiovascular intervention with the acquisition of California-based Shockwave Medical Inc. J&J and the target announced a definitive agreement ...
A large number of eyes could be on a fast-growing technology used to modify plaque in arteries as attendees gather in Paris for this year’s EuroPCR. Intravascular lithotripsy (IVL) has become ...
Johnson & Johnson acquired medtech company Shockwave Medical for $13.1 billion, the pharma giant announced Friday morning. The deal, which has been approved by the board of directors of both companies ...
NEW BRUNSWICK, N.J. & SANTA CLARA, Calif.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) and Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave”) today announced that they have entered into a ...
Novel Intravascular Lithotripsy (IVL) catheter demonstrates ability to modify calcium safely, enabling treatment and crossing of tightly-stenosed lower limb lesions Technology has received U.S. FDA ...
Balloon lithotripsy better prepared severely calcified lesions for stenting compared with conventional techniques, based on results of intravascular imaging in the small, 200-person BALI trial. Among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results